Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain
about
Biophysical studies of matrix metalloproteinase/triple-helix complexesMatrix metalloproteinase interactions with collagen and elastinCollagenolytic Matrix Metalloproteinase Activities toward Peptomeric Triple-Helical SubstratesPath to Collagenolysis: COLLAGEN V TRIPLE-HELIX MODEL BOUND PRODUCTIVELY AND IN ENCOUNTERS BY MATRIX METALLOPROTEINASE-12.The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavageMatrix metalloproteinases as breast cancer drivers and therapeutic targets.MMP-13 is involved in oral cancer cell metastasis.MMP-13 is constitutively produced in human chondrocytes and co-endocytosed with ADAMTS-5 and TIMP-3 by the endocytic receptor LRP1Low density lipoprotein receptor-related protein 1 (LRP1)-mediated endocytic clearance of a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4): functional differences of non-catalytic domains of ADAMTS-4 and ADAMTS-5 in LRP1 bUsing Small Angle X-Ray Scattering (SAXS) to Characterize the Solution Conformation and Flexibility of Matrix Metalloproteinases (MMPs).Structural requirements for the collagenase and elastase activity of cathepsin K and its selective inhibition by an exosite inhibitor.Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer.Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) - experimental validation in human breast and colon cancer.
P2860
Q26866074-BEADA7FA-C10C-492C-93AF-A6C7598239BDQ26996437-6756BE5E-936E-4D55-9FCC-7ACCA3D51F0AQ27301783-FB0846BE-F763-4552-B3FF-F2B7FF384368Q30739775-8899D6F9-EB19-4C68-A177-C9664781FBECQ35204098-6477B1EE-28D9-42E2-AAB7-C4DA91D68771Q35892721-6262DFDB-D6BF-40FA-8949-C73A1FA2D6EAQ37086224-0F7DD9B3-CDFD-408A-ABE7-81CF51DEFCFFQ37488265-E8E9F7FC-6C8A-4AB9-B750-DE2524B5066DQ37622540-E49FE354-21AE-4464-ACBB-9AA9F1414562Q38904215-1B6C02CE-5536-4EEE-A35C-55455EECC722Q42686277-54A73D38-EBBF-4398-9956-DCF057F5D515Q42720277-CD88BD16-C340-4CF6-88C5-8134E77F5783Q50790658-6850EF62-EAB7-4E1B-B11A-97B40F36AEC2
P2860
Crystal structure of full-length human collagenase 3 (MMP-13) with peptides in the active site defines exosites in the catalytic domain
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Crystal structure of full-leng ...... osites in the catalytic domain
@ast
Crystal structure of full-leng ...... osites in the catalytic domain
@en
Crystal structure of full-leng ...... osites in the catalytic domain
@en-gb
Crystal structure of full-leng ...... osites in the catalytic domain
@nl
type
label
Crystal structure of full-leng ...... osites in the catalytic domain
@ast
Crystal structure of full-leng ...... osites in the catalytic domain
@en
Crystal structure of full-leng ...... osites in the catalytic domain
@en-gb
Crystal structure of full-leng ...... osites in the catalytic domain
@nl
prefLabel
Crystal structure of full-leng ...... osites in the catalytic domain
@ast
Crystal structure of full-leng ...... osites in the catalytic domain
@en
Crystal structure of full-leng ...... osites in the catalytic domain
@en-gb
Crystal structure of full-leng ...... osites in the catalytic domain
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
Crystal structure of full-leng ...... osites in the catalytic domain
@en
P2093
Hideaki Nagase
Philippe Cuniasse
Robert Visse
Vincent Dive
P2860
P304
P3181
P356
10.1096/FJ.13-233601
P407
P50
P577
2013-11-01T00:00:00Z